The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nucleic Acids Extraction and QC
1.2.3 Gene Expression Services
1.2.4 Genotyping Services and Pharmacogenomics
1.2.5 Data Analysis and Interpretation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Genomics Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical
1.3.4 Research Institutes
1.3.5 Agrochemical
1.3.6 Chemical
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics Solutions Market Perspective (2018-2029)
2.2 Genomics Solutions Growth Trends by Region
2.2.1 Global Genomics Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomics Solutions Historic Market Size by Region (2018-2023)
2.2.3 Genomics Solutions Forecasted Market Size by Region (2024-2029)
2.3 Genomics Solutions Market Dynamics
2.3.1 Genomics Solutions Industry Trends
2.3.2 Genomics Solutions Market Drivers
2.3.3 Genomics Solutions Market Challenges
2.3.4 Genomics Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics Solutions Players by Revenue
3.1.1 Global Top Genomics Solutions Players by Revenue (2018-2023)
3.1.2 Global Genomics Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Genomics Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics Solutions Revenue
3.4 Global Genomics Solutions Market Concentration Ratio
3.4.1 Global Genomics Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Solutions Revenue in 2022
3.5 Genomics Solutions Key Players Head office and Area Served
3.6 Key Players Genomics Solutions Product Solution and Service
3.7 Date of Enter into Genomics Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics Solutions Breakdown Data by Type
4.1 Global Genomics Solutions Historic Market Size by Type (2018-2023)
4.2 Global Genomics Solutions Forecasted Market Size by Type (2024-2029)
5 Genomics Solutions Breakdown Data by Application
5.1 Global Genomics Solutions Historic Market Size by Application (2018-2023)
5.2 Global Genomics Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genomics Solutions Market Size (2018-2029)
6.2 North America Genomics Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genomics Solutions Market Size by Country (2018-2023)
6.4 North America Genomics Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomics Solutions Market Size (2018-2029)
7.2 Europe Genomics Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genomics Solutions Market Size by Country (2018-2023)
7.4 Europe Genomics Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics Solutions Market Size (2018-2029)
8.2 Asia-Pacific Genomics Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genomics Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Genomics Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomics Solutions Market Size (2018-2029)
9.2 Latin America Genomics Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genomics Solutions Market Size by Country (2018-2023)
9.4 Latin America Genomics Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics Solutions Market Size (2018-2029)
10.2 Middle East & Africa Genomics Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genomics Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Genomics Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10X Genomics Inc.
11.1.1 10X Genomics Inc. Company Detail
11.1.2 10X Genomics Inc. Business Overview
11.1.3 10X Genomics Inc. Genomics Solutions Introduction
11.1.4 10X Genomics Inc. Revenue in Genomics Solutions Business (2018-2023)
11.1.5 10X Genomics Inc. Recent Development
11.2 Abcam Plc
11.2.1 Abcam Plc Company Detail
11.2.2 Abcam Plc Business Overview
11.2.3 Abcam Plc Genomics Solutions Introduction
11.2.4 Abcam Plc Revenue in Genomics Solutions Business (2018-2023)
11.2.5 Abcam Plc Recent Development
11.3 Exeter Clinical Laboratory
11.3.1 Exeter Clinical Laboratory Company Detail
11.3.2 Exeter Clinical Laboratory Business Overview
11.3.3 Exeter Clinical Laboratory Genomics Solutions Introduction
11.3.4 Exeter Clinical Laboratory Revenue in Genomics Solutions Business (2018-2023)
11.3.5 Exeter Clinical Laboratory Recent Development
11.4 Psomagen
11.4.1 Psomagen Company Detail
11.4.2 Psomagen Business Overview
11.4.3 Psomagen Genomics Solutions Introduction
11.4.4 Psomagen Revenue in Genomics Solutions Business (2018-2023)
11.4.5 Psomagen Recent Development
11.5 BGI Genomics Co. Ltd.
11.5.1 BGI Genomics Co. Ltd. Company Detail
11.5.2 BGI Genomics Co. Ltd. Business Overview
11.5.3 BGI Genomics Co. Ltd. Genomics Solutions Introduction
11.5.4 BGI Genomics Co. Ltd. Revenue in Genomics Solutions Business (2018-2023)
11.5.5 BGI Genomics Co. Ltd. Recent Development
11.6 Bio Rad Laboratories Inc.
11.6.1 Bio Rad Laboratories Inc. Company Detail
11.6.2 Bio Rad Laboratories Inc. Business Overview
11.6.3 Bio Rad Laboratories Inc. Genomics Solutions Introduction
11.6.4 Bio Rad Laboratories Inc. Revenue in Genomics Solutions Business (2018-2023)
11.6.5 Bio Rad Laboratories Inc. Recent Development
11.7 Danaher Corp.
11.7.1 Danaher Corp. Company Detail
11.7.2 Danaher Corp. Business Overview
11.7.3 Danaher Corp. Genomics Solutions Introduction
11.7.4 Danaher Corp. Revenue in Genomics Solutions Business (2018-2023)
11.7.5 Danaher Corp. Recent Development
11.8 Eppendorf AG
11.8.1 Eppendorf AG Company Detail
11.8.2 Eppendorf AG Business Overview
11.8.3 Eppendorf AG Genomics Solutions Introduction
11.8.4 Eppendorf AG Revenue in Genomics Solutions Business (2018-2023)
11.8.5 Eppendorf AG Recent Development
11.9 Eurofins Scientific SE
11.9.1 Eurofins Scientific SE Company Detail
11.9.2 Eurofins Scientific SE Business Overview
11.9.3 Eurofins Scientific SE Genomics Solutions Introduction
11.9.4 Eurofins Scientific SE Revenue in Genomics Solutions Business (2018-2023)
11.9.5 Eurofins Scientific SE Recent Development
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Detail
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. Genomics Solutions Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Genomics Solutions Business (2018-2023)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Development
11.11 CD Genomics
11.11.1 CD Genomics Company Detail
11.11.2 CD Genomics Business Overview
11.11.3 CD Genomics Genomics Solutions Introduction
11.11.4 CD Genomics Revenue in Genomics Solutions Business (2018-2023)
11.11.5 CD Genomics Recent Development
11.12 Illumina
11.12.1 Illumina Company Detail
11.12.2 Illumina Business Overview
11.12.3 Illumina Genomics Solutions Introduction
11.12.4 Illumina Revenue in Genomics Solutions Business (2018-2023)
11.12.5 Illumina Recent Development
11.13 qGenomics
11.13.1 qGenomics Company Detail
11.13.2 qGenomics Business Overview
11.13.3 qGenomics Genomics Solutions Introduction
11.13.4 qGenomics Revenue in Genomics Solutions Business (2018-2023)
11.13.5 qGenomics Recent Development
11.14 IQVIA
11.14.1 IQVIA Company Detail
11.14.2 IQVIA Business Overview
11.14.3 IQVIA Genomics Solutions Introduction
11.14.4 IQVIA Revenue in Genomics Solutions Business (2018-2023)
11.14.5 IQVIA Recent Development
11.15 Beckman Coulter
11.15.1 Beckman Coulter Company Detail
11.15.2 Beckman Coulter Business Overview
11.15.3 Beckman Coulter Genomics Solutions Introduction
11.15.4 Beckman Coulter Revenue in Genomics Solutions Business (2018-2023)
11.15.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details